FTC judge says Impax should settle
Federal Trade Commission building (Credit: Wikimedia)
Impax Laboratories should settle the Federal Trade Commission’s allegations that it entered into a pay-for-delay agreement with Endo Pharmaceuticals, an administrative law judge suggested on Thursday.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10